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Stochastic modellingUsing a stochastic simulation without any other hypotheses, we recently demonstrated the natural
emergence of the modiﬁed Mitchell Q-cycle in the functioning of the bc1 complex, with few short-circuits
and a very low residence time of the reactive semiquinone species in the Qo site. However, this simple model
fails to explain both the inhibition by antimycin of the bc1 complex and the accompanying increase in ROS
production. To obtain inhibition, we show that it is necessary to block the return of the electron from the
reduced haem bL to Qo. With this added hypothesis we obtain a sigmoid inhibition curve due to the fact that
when only one antimycin is bound per bc1 dimer, the electron of the inhibited monomer systematically
crosses the dimer interface from bL to bL to reduce a quinone or a semiquinone species in the other (free) Qi
site. Because this step is not limiting, the activity is unchanged (compared to the activity of the free dimer).
Interestingly, this bL–bL pathway is almost exclusively taken in this half-bound antimycin dimer. In the free
dimer, the natural faster pathway is bL–bH on the same monomer. The addition of the assumption of half-of-
the-sites reactivity to the previous hypothesis leads to a transient activation in the antimycin titration curve
preceding a quasi-complete inhibition at antimycin saturation.rdeaux 2, 146 rue Léo-Saignat,
6.
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We recently demonstrated [1] that we can explain the bifurcation
of electrons in the Qo site of the bc1 complex by using a stochastic
simulation with the crystal structure, together with the knowledge of
the midpoint potentials of the individual redox centres and the ISP
head movement. We then observe the natural emergence of the
“modiﬁed” Mitchell Q-cycle [2–5] with few short-circuits and a low
residence time of the reactive semiquinone species in the Qo site
without any other hypotheses. In this model, the two electrons are
transferred sequentially from the QH2 molecule bound in Qo, but the
second electron transfer to bL follows the ﬁrst one onto FeS so rapidly
that it appears concerted. It is a sequential concerted-like transfer of
the two QH2 electrons. Importantly, the bifurcation of the two QH2
electrons occurs naturally in Qo without any gating mechanism to
prevent the second electron from following the ﬁrst one on the FeS-
c1-c pathway (short-circuits [6,7] also called bypasses [8,9]).
However, inhibition of the bc1 complex by antimycin A cannot be
reproduced in this simple model. Furthermore, in our current model,
there is not only no inhibition of the bc1 complex activity by antimycin
but also an increase in the activity due to a bypass for the second
electron blocked by antimycin on haem bL.Indeed, in the framework of Q cycle hypothesis, there is no
fundamental reason for which antimycin should inhibit bc1 complex
activity. Antimycin binds to the Qi site and in principle does not
interfere with the bifurcation of the electrons in the Qo site: while
antimycin inhibits one pathway, it does not necessarily inhibit the
other one. The electron blocked on bL by antimycin can return on a
semiquinone SQ in Qo and then follow the high potential pathway
(bypass of type 2 or short-circuit 2) [6–9].
Because the inhibition has to be effective in (or close to) the Qo site
and because antimycin binds to the Qi site far from the Qo site, many
authors have consequently assumed that antimycin binding at Qi
transmits some signal to the Qo site. Several implicit or explicit
hypotheses have been made concerning the nature of this signal. It
seems clear that it is not of a transconformational type. To date, no
change has been apparent in the different crystal structures where
antimycin is bound. However it should be emphasized that the Qo site
in all these structures is also occupied by an inhibitor (stigmatellin)
that can block a possible conformational change.
Several authors [6,7,10–13] have underlined the need for gating
processes (in Qo) to avoid bypasses. An attractive hypothesis was put
forward by Crofts et al. (reviewed in Ref. [13]). They propose the
existence of two subsites in Qo, one close to FeS (and far from bL) and
the other one close to bL (and far from FeS). They also assume
coulombic interaction between a reduced bL and the semiquinone SQ
in Qo which shouldmaintain this semiquinone far from the reduced bL
and prevent the electron return from bL to SQ in Qo. We study this
hypothesis in our model.
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necessarily linear in spite of its rather high afﬁnity, but that it could be
parabolic (sigmoid). A ﬁrst explanation was given by Kröger and
Klingenberg [14,15] in terms of diffusible quinones: partial inhibition
of the bc1 complex would have no effect on the total electron transfer
rate as long as the reaction of the bc1 complex is not rate-limiting. One
would now refer to it as not controlling in the light of metabolic
control analysis [16–18]. However, this behaviour is also encountered
with the isolated complex, a phenomenon that cannot be explained by
the buffering effect of a “quinone pool.” This was analyzed by
Bechmann et al. [19] who obtained parabolic or linear antimycin
inhibition curves, depending upon the different quinols used. With
mitochondria from beef heart, the shape of the inhibition curve with
antimycin A is parabolic if the quinol-cytochrome c reductase turns
over at about 300 s−1, but it is hyperbolic if the rate is 5-fold lower.
They proposed the new hypothesis of a rapid intra- and inter-dimeric
redistribution of antimycin at substoichiometric concentrations
exchanging via the lipid phase and substantiated it with a model
that accounts well for their results.
Another explanation was developed when the ﬁrst crystal
structures of bc1 complex became available, showing that the two
haem bL in the dimer were close enough to allow the passage of
electrons between each other. Experimental attempts to evidence
such passages proved unfruitful, however [11], or were observed only
in special conditions [20]. In our simulations reported in Ref. [1], we
noted some rare net movement of electrons between the two bL of the
same dimer in accordancewith the experimental data. As noted in Ref.
[21], the direct electron transfer from haem bL to haem bH of the same
monomer is promoted, at least in the absence of a proton motive
force.
However, as stressed in Ref. [6], the existence of a bL–bL transition
“helps to explain how the ﬁrst substoichiometric fraction of antimycin
that binds, inhibits noticeably less effectively than the ﬁnal fraction”.
These authors also noted that “this removes the strict coupling
between two turnovers of one Qo site and one Qi site described in the
traditional double Q-cycle model”. This was also noticed by Covian et
al. [22] in support of a more complicated mechanism of half-of-the-
sites reactivity for ubiquinol oxidation and rapid electron transfer
between bc1 monomers. They also observed a stimulation of the
activity of the bc1 complex at a substoichiometric fraction of
antimycin and proposed that this was a consequence of the half-of-
the-sites reactivity. They recently provided new evidence for such
mechanism with the elegant construction of a heterodimer [23] in
which the stimulation by low antimycin concentrations vanished.
Explaining antimycin inhibition therefore seems crucial in under-
standing the mechanism of bc1 complex functioning, because it
probably mimics what occurs in the presence of proton motive force
when haems bL and bH are more reduced than in its absence.
In this paper we use our stochastic model to test some of the
hypotheses put forward to explain antimycin inhibition and its
peculiar characteristics. We show that preventing the return of the
electron from haem bL to SQ in Qo is absolutely necessary and also
sufﬁcient to obtain antimycin inhibition. The latter is parabolic
(sigmoid) due to an increase in bL–bL transition when only one
antimycin molecule per dimer is bound. We also analyze the effects of
the half-of-the-sites reactivity hypothesis on the shape of the
antimycin inhibition curve.
2. Methods/model
2.1. Methods/model
The model is fully described in Ref. [1], with some minor changes
in the parameters and the rate constants quoted in Tables S1 and S2 in
supplementary materials. There was a sign error in Eq. (2) [1] which is
corrected below. Simulations made at different substrate concentra-tions allowed us to evaluate the KM for substrates. These values
depend upon the binding and release rate constants (italicized values
in Table S2). They were chosen in order to obtain KM values similar
to those reported in the literature. With the parameter data set
listed in Table S2, we obtained kcat=182 s−1 (per monomer),
KM QH2=3.1 μM; KM cyt c=2.2 μM. We also obtained inhibition at a
high Q concentration (KI=70 μM) and a Q activation at low
concentration (KA=66 nM). The electron tunnelling rate constants
from which we derive the probabilities of reactions are calculated
according to Moser et al. [24–26]:
log kexeret = 13−ð1:2−0:8ρÞðD−3:6Þ−γ
ðΔGoexer + λÞ2
λ
ð1Þ
for the exergonic direction of the reactions or:
log kenderet = 13−ð1:2−0:8ρÞðD−3:6Þ−γ
ðΔGoexer + λÞ2
λ
+
ΔGoexer
0:06
= logkexeret +
ΔGoexer
0:06
ð2Þ
for the endergonic direction of the reaction.
“exer” means exergonic and “ender” means endergonic. The ΔG°
values used as well as the distance (D) are shown in Table S2 of
supplementary materials.
ΔG°exer are calculated from the midpoint redox potentials listed in
Table S1. ρ is the packing density which is around 0.76 in a typical
protein [25]. λ is the reorganization energy (in eV); 0.7 eV seems to be
an adequate generic value [25], γ=4.23 eV−1 is derived from the
classical Marcus expression [27–29]. Moser et al. [24–26] use
γ=3.1 eV−1. When the classical Marcus treatment was used with
γ=4.23 eV−1, these two forms of the rate equation (Eqs. (1) and (2))
gave identical results (see the discussion in Ref. [28]). The rate
constants (forwards and backwards) in Table S2 used in all our
simulations were calculated using Eq. (1) with this latter value of
γ=4.23 eV−1.
We used 51 different crystallographic bc1 structures to calculate
the various distances between the redox centres and/or substrates
or the products bound in the binding sites. All the 51 structures
were used to estimate the bL–bL and bL–bH distances without
weighting the values according to the resolution of the crystallo-
graphic structure, because these distances are very reproducible in
all structures from all species (12.2±0.2 Å and 13.9±0.4 Å). When
the substrates/products are concerned, or the position of the FeS
cluster, only part of the set of structure can be used, and sometimes
only one.
The time course of the reaction is calculated using the Gillespie
algorithm [30] as described in Ref.[1].
Weworkwith only one bc1molecule and 300QH2molecules, 100Q
molecules and 600 oxidized cytochrome c in a volume v=3.3 10−17 L.
These values aim at reproducing the in vitro conditions of the enzyme
assay (after [31]). Each simulation lasts 0.5 s of reaction time.
To simulate the antimycin inhibition curves, we calculate the
concentrations of the different antimycin-bound species of the bc1
complex E1E2, E1IE2, E1E2I and E1IE2I (I stands for antimycin
inhibitor) as in Ref. [31], assuming a total concentration of 50 nM bc1
complex (Fig. 1; see also an example of such calculations of
concentrations in Table S3 in supplementary materials). Then we
calculate the mean of 5 time courses for one molecule of each species
(one free bc1, one bc1 dimer with one antimycin and one bc1 dimer
with two antimycin molecules) and express the resulting activity as
the linear combination of the individual average activities propor-
tionally to their concentrations.
Fig. 1. Distribution of the different antimycin bound bc1 dimers. The concentrations are
calculated as described in Model section with Ki (antimycin)=0.2 nM and [bc1]=50
nM. Free bc1 in blue, bc1 dimer with one antimycin molecule in red, bc1 dimer with 2
antimycin molecules in green, free bc1+bc1 dimer with one antimycin molecule in
violet.
1851S. Ransac, J.-P. Mazat / Biochimica et Biophysica Acta 1797 (2010) 1849–18573. Results and discussion
3.1. The simple model does not account for antimycin inhibition
In the simple stochastic model of bc1 complex functioning that we
proposed in Ref. [1], the primary event is the passage of the ﬁrst QH2
electron on FeS. Although the electron transfer is uphill, it is the only
possibility (Fig. 2), so it may be one of the controlling steps in the
process. Once the ﬁrst electron has jumped to FeS, three reactionsmay
occur. (i) Themost probable is the return of this ﬁrst electron on SQ to
give back QH2. It is a very likely possibility which occursmany times in
our simulation and which brings the system back to its initial state.
We will not consider further this situation except for taking into
account the delay it introduces in the overall reaction. The other two
sequences of events are (ii) themovement of the ISP head towards the
cytochrome c1 taking the electron away from the Qo site and placing
the second electron in the instable SQ in a very favourable position to
be transferred to bL (Figs. 2 and 3A). On the other hand, (iii) the
second electronmay jump to bL during the time the ﬁrst electron is on
FeSQ (close to Qo) before the head has moved to c1 (Fig. 3B). In the
latter mechanism, as soon as the second electron jumps to bL, the ﬁrst
one is trapped on FeS because themidpoint potential of Q/SQ becomes
quasi unattainable. In both cases, the transfer of the two QH2 electrons
is sequential but so rapid that it may appear as concerted. The choiceFig. 2. The energetics of the electron transfers at the Qo site. The values in brackets in black i
italics and in brackets along the arrows are the distances between the redox centres. The ra
related to the intensity of the rate constants. Dotted arrows correspond to unfavoured evenbetween these two sequences (Fig. 3A and B) will depend upon the
rate of ISP movement. At high rate the ﬁrst sequence (Fig. 3A) will be
triggered while at lower ISP head shift, the other scenario (Fig. 3B)
will occur. One or the other of these sequences underpins the
mechanism of the Mitchell Q-cycle, which is based on the bifurcation
of the electrons at Qo. This interplay between the rate constants
responsible for this concerted-like sequential mechanism has already
been described by Rich in Ref. [32] (see beginning of Section 3). In
some cases the bifurcation fails in what is called bypasses [8,9] or
short-circuits [7]. The most frequent of these are represented in Fig. 4.
In type 1 bypass, the second QH2 electron goes directly to FeS. In type
2 bypass, the second electron returns from the reduced bL on a new SQ
molecule and gives back a new quinol QH2, one electron of which
normally goes to FeS. It is as if the second electron transiently stored
on bL returns to FeS. The number and the type of short-circuits will
also somewhat depend upon the ISP head displacement rate. Fig. 5
shows that the global rate of the reaction increases when the
displacement velocity of the ISP head increases. This increase is
accompanied by a slight increase in both types of short circuits, as
shown in Fig. 4. The value of 60,000 s−1 given by Millett & Durham for
the rate of ISP headmovement [33] and represented by a yellow point
in Fig. 5 corresponds to the sequence of events B in Fig. 3 (the ﬁrst
electron is trapped on FeS while the second is transferred to bL). It
stands in a region for which the number of short-circuits is low. In the
following we take this value of 60,000 s−1 for the ISP head
displacement (in both directions).
However, in the presence of antimycin, the simulations conducted
with this model do not evidence any inhibition (Fig. 6). On the
contrary, the rate increases due to an increase in type 2 bypass (blue
curve on Fig. 6), because in the presence of antimycin, the haem bL is
mainly reduced. At antimycin saturation, all the QH2 electrons go to
FeS and then to c1 and c, one directly and the other one through bL
(type 2 bypass). The number of bypasses is exactly half of the number
of reduced cytochrome c (Fig. 6). We then observe an increase in the
rate because both electrons of each QH2 reduce two cytochrome c
molecules instead of one in the normal functioning of the complex.
3.2. What are the characteristics of antimycin inhibition?
To explain the role of antimycin, we have to take into account the
following salient features of antimycin inhibition: (i) its inhibitory
effect i.e. a decrease (close to zero) in the activity of the bc1 complex;
(ii) the ROS production associated with antimycin binding and
presumably following an increase in semiquinone SQ at Qo; and
(iii) the oxidant-induced reduction of bc1 complex [34,35], i.e. the facttalics above the sites are the midpoint potentials of the redox couples. The values in red
te constants are indicated in dark red along the arrows. The thickness of the arrows is
ts.
Fig. 3. Sequences of electron transfers at Qo depending on the rate of ISP head displacement. The thickness of the arrows is proportional to the probability of transfer. (A) Rapid
motion of the ISP head. (B) Slow motion of the ISP head (60,000 s−1 as reported in Ref. [33]).
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b-type haems are reduced whereas cytochrome c1/c are oxidized.
As detailed in Introduction, several models have been proposed to
account implicitly or explicitly for antimycin inhibition. They form
two main types: (i) models which assign to bL, when reduced, special
effects on the electron (and proton) movements in Qo [10–13,27,36–
38]; (ii) models which involve a kind of half-of-the-sites reactivity,
implying that only one monomer of the bc1 dimer is active at a time
[20,22,23,31,39].
We describe in more detail the features of the ﬁrst class of models
and analyse their consequences with the help of our stochastic model.
In this way, we can explore the mechanism of electron transfers at Qo
site. Finally we study the consequences of introducing half-of-the-
sites reactivity on antimycin inhibition.
3.3. Two subsites in Qo?
Based on the structures of the Qo site and on the observation that
there are two classes of inhibitors with different binding in the Qo site
producing different effects, Crofts and others proposed that there are
two subsites in Qo, one close to the FeS (7 Å from FeS and 12.4 Å from
bL) called the distal site (from bL; we refer to it as Qof) and the other
close to bL called the proximal site (we refer to it as Qob) (6.3 Å frombL)
[10–13,27,40,41]. The idea is that QH2 binds ﬁrst to Qof close to FeS,
gives its ﬁrst electron to FeS, becoming SQ,whichmoves to Qob close to
bL thereby giving it its second electron. In other words, the quinol/
semiquinonemolecule is always close to the acceptor to which it gives
its electron. Hong et al. [41] “favoured this mechanism because of the
need to minimize harmful short-circuit reactions by keeping [SQ]
occupancy to a minimum” [13]. To test this hypothesis, we added into
our simple model the presence of two subsites Qof and Qob with a
possible stochastic transfer of the quinoneQ/semiquinone SQ fromone
site to the other (QH2 is thought to remain in Qof). Fig. 7 represents theFig. 4. Short-circuits (bypasses) that can occur at Qo (type 1 and type 2). The order of electron
electron 2, e−2’, because it is normally the second electron of a previous QH2 molecule.activity of the reaction as a function of the distance between the two
sub sites (i.e. the distance Qof–Qob). We start at the Qo position of our
model (Q/SQ/QH2 at 6.9 Å from FeS and 11.2 Å from bL) [1], i.e.
assuming that the two sites overlap, then we move Qob away from Qof
(Qof remains at its initial position) and we study the rate of the global
reaction, the possible short-circuits and the residence time of SQ at Qo.
As shown in Fig. 7, the behaviour depends upon the rate of
quinone species displacement between the two subsites. When the
rate is slow, the second electron although far from bL (11.2 Å) is able
to jump to bL from position Qof before the SQ molecule moves to Qob.
In this case, the rate of the global reaction activity is unchanged.
When the rate of quinone species displacement between both sites is
increased, the transfer of the second electron is facilitated (closer to
bL) so the activity is increased (with no signiﬁcant changes in the
residence time of the semiquinone at Qo (not shown)). This could
explain the higher activity observed in the Rhodobacter bc1 complex
in pre-steady state experiments [29]. An enhancement of the rate
constant of bL reduction due to a movement of SQ inside Qo was
already proposed by Crofts et al. a long time ago (see the discussion
in Ref. [11,13,41,42]). However, even if we suppose that, for reasons
of charge repulsion, SQ is conﬁned to Qof far from reduced bL, adding
antimycin does not prevent the electron of reduced bL from jumping
to SQ to begin the short-circuit of type 2, leading to an increase in
activity, as in the simple model (compare Figs. 8 and 6).
Thus even an SQ distance of approximately 12 Å from the reduced
haem bL does not in itself impede the back ﬂow of the bL electron on
SQ and does not lead to antimycin inhibition. Another hypothesis is
therefore required.
3.4. A hypothesis for obtaining antimycin inhibition
Although the two Qo subsites hypothesis is not a satisfactory
explanation for antimycin inhibition, it does again show that onetransfer is indicated by the circled red digits. In type 2 short-circuit, a prime is added to
Fig. 5. Effect of the speed of ISP head displacement on the global rate constant. Red
(circle), left scale bc1 activity (cytochrome c reduced per second); green (triangle),
right scale, SQ lifetime in Qo; black, left scale number of type 1 bypasses per second
(SQ ➔ FeS); blue type 2 bypasses (bL ➔ SQ). The large yellow point corresponds to the
60,000 s–1 value taken in the following according to [33].
Fig. 7. Effect of the distance between two subsites at Qo. In abscissa the distance
between two subsites Qof close to FeS and Qob close to haem bL. The origin corresponds
to the two sites overlapping the initial position as in Fig. 6 (6.9 Å from FeS and 11.2 Å
from bL). The Qof site is conserved in this position and the Qob site is displaced from the
distance indicated in abscissa in the direction to bL, so that the distance (Qof−Qob)+
(Qob−bL)=11.2 Å. The different curves correspond to different rates of transition of
the SQ molecules (and possibly of all other species of quinone/quinol) between both
sites.
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activity of bc1 complex is the existence of type 2 bypass when bL is
maintained reduced (Figs. 6 and 8). Thus we must suppose that for
some reason, when bL is reduced, the bL electron cannot return to the
SQ at Qo. This hypothesis was already suggested by Crofts et al. [13].
Fig. 9 shows that this hypothesis is sufﬁcient to obtain antimycin
inhibition provided that both antimycin sites are occupied. The
reason for the inhibition is that the Qo site is mainly occupied by QH2
(Table 1) because the electron jump to FeS is not facilitated owing to
its higher midpoint potential. The ﬁrst QH2 electron can no longer be
trapped at FeS by the passage of the second electron on the haem bL,
which is already reduced in the presence of antimycin. The situation
is thus: (FeSox–QH2–bLred) with some short and rapid transitions toFig. 6. Effect of antimycin with the simple model described in [1]. Left scale: In red:
activity in s–1; in blue, number of type 2 bypasses per second (bL➔ SQ); the black bell-
shape curve, bLbound ➔ bLfree, indicates the net number of bL2 ➔ bL1 transitions per
second (antimycin in Qi2) + net number bL1 =N bL2 transitions per second (antimycin
in Qi1). Right scale (in green): lifetime of semiquinone at Qo.(FeSred–SQ–bLred), which quickly return to the previous situation
faster than the head motion. Thus FeS is mainly oxidized (see Table 1)
and its displacement to c1, if any, has little chance of carrying any
electron. For this reason, the reduction of bL in the absence of
antimycin, and presumably the reduction of bH which follows very
rapidly, normally precede the reduction of c1, as observed by Yu et al.
[36,37]. This is because the electrons move faster than the ISP head
and do not necessarily cause ISP head motion. However, in the
presence of only one antimycin per dimer, we found paradoxically
that the catalytic rate is not affected (288.4±12.8 s−1 for the free
dimer and 288.0±9.4 s−1 for the dimer with only one boundFig. 8. Effect of antimycin on the two Qo subsites model. The quinone species
displacement rate between the two subsites Qof and Qob (distant from 5 Å) is 5.108 s−1.
Colour as in Fig. 6. In red, left scale, activity in s−1; in blue, left scale, number of type 2
bypasses per second (bL ➔ SQ); in black, left scale, net number of bLbound ➔ bLfree
transitions per second; in green, right scale, lifetime of semiquinone at Qo (SQ on right
scale).
Fig. 9. Proposed model of antimycin inhibition. In this model it is assumed that the
return of the second electron of bLred on SQ•- is impossible. The colours are the same as
in Fig. 6: activity (red curve, left scale); time residence of SQ in Qo (green curve, right
scale). The black curve (left scale) indicates the net number of bLbound ➔ bLfree
transitions per second. The blue curve indicates the low number of SQ ➔ FeS bypass
due to a low probability of return of the bL electron on a Q molecule at Qo through a
transient formation of a semiquinone molecule SQ (See Fig. 11) in Qo which
immediately gives its electron to FeS.
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so the inhibition curve of Fig. 9 is more or less similar to the “free
bc1+1 antimycin/ bc1” curve in Fig. 1 in line with experimental
results (e.g. [19]).
When looking for the sequence of electrons transfers in the half-
occupied dimer, we found an abnormally high number of i) bL2=N bL1
net passages when antimycin was bound to monomer 2 and ii) net
passages bL1 =N bL2 when antimycin was bound to monomer 1
(amounting to 147±12per second for the full activity of 288±9 s−1).
This means that the Qo site of the monomer occupied by antimycin
functions normally like the Qo site of the other (free) monomer, but
with its second electron going to theQi site of the othermonomer (see
Fig. 10). This is in line with the observation that a controlling step of
the process is the transfer of the ﬁrst electron to FeS. Even if the
bL1 b=NbL2 transition is not rapid, it is faster than the steps involved in
the high potential pathway (Qo =N FeS =N c1 =N c), so two such
events have time to occur meanwhile at Qi1 (resp. Qi2). In the free
dimer, the cross route bL1 b=N bL2 is more rarely used because the
bL =N bH route is faster. However, if this bL =N bH electron transfer is
slowed down in the free dimer, e.g. due to the setting up of the
membrane potential, the bL1 b=N bL2 transition could be favoured
again, but in this casewith an equal passage in both directions (see the
discussion in Ref. [21]).
This behaviour gives the antimycin inhibition curve its coopera-
tive shape (Fig. 9) and fulﬁls the two other salient features of
antimycin inhibition: the increase in the lifetime of SQ at the Qo site
(green curve on Fig. 9) and the oxidant-induced reduction of cyt b
(Table 1).
In our conditions, inhibition is not complete. This is partly due to
the 0.8% half-inhibited enzyme still present at an antimycin/bc1 ratio
of 3 (see Table S3 of supplementary data) but also to a rare bypass
represented in Fig. 11 in which there occurs the release of QH2 from
Qo and its replacement by a quinone Q. Although it is very
unfavourable the Q molecule can now accept the electron from the
reduced bL to form SQ and give it immediately to FeS to give back Q.
Because bL is now oxidized, a normal cycle of reactions can then occur
with another reduction of cytochrome c. The residual activity is thus
twice the number of bypasses. This possibility is favoured in our
Fig. 10. Scheme of the oriented passage bL1 ➔ bL2 from the inhibited monomer to the
free monomer.
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the quinol QH2 concentration. In physiological conditions with
antimycin, Q will be reduced by complex I or II in QH2 and the
antimycin inhibition will appear nearly complete.
The transition bL2 =N bL1 or bL1 =N bL2 in the half-inhibited dimer
is a natural mechanism that can simply account for the sigmoid shape
of the antimycin curve.
However, the transition bL b=N bL is controversial and seems
difﬁcult to evidence experimentally. For instance, in the presence of
saturating amounts of antimycin, a linear decrease of the bH reduction
as a function of myxothiazol concentration was observed by Crofts et
al. (see Fig. 4 in [11]). This means that no electron from a free Qo site
jumped to the bL of the othermonomer of a myxothiazol-bound site at
least during the ﬁrst 20 ms of measurement.
This leads us to discuss other models which have been proposed,
particularly the one by Kröger and Klingenberg [14,15] who explain
this non-hyperbolic inhibition in terms of a diffusible ubiquinone and
QH2 connecting the respiratory chain complexes. Bechmann et al. [19]
explain this inhibition pattern by assuming that "antimycin A moves
rapidly between the inhibition sites at the centre i of the dimeric
enzyme". They also hypothesize a fast electron transfer between the
two haems bH of the dimer in the presence of only one bound
antimycin.
Both groups noted that the shape depends intriguingly upon the
type of quinone used. For example, Bechmann et al. [19] linked theFig. 11. Bypass of a bL electron on a Q molecule bound to Qo (uphill, low probability)
followed by its rapid transfer to FeSox (downhill) through the transient formation of a
semiquinone. This bypass is slightly favoured in our simulations where we took [Q] is
not negligible.parabolic shape of the curve to a high activity of the bc1 complex, a
hyperbolic curve being recorded with less efﬁcient quinone. This
could mean that the afﬁnity of these different quinones or their redox
potential [15] might play a role in shaping the antimycin response.
Indeed, any factors (afﬁnity or redox potential) reducing their
reduction rate in Qi will increase the reduction of bH and thus bL on
the same monomer and then decrease the possible occurrence of
bL =N bL transfer from the other monomer, thus decreasing the global
activity. Fig. 13A simulates the effect of a decrease in quinone afﬁnity
to the Qi site and demonstrates a clear transition from a sigmoid to a
hyperbolic shape associated with a decrease in the activity. The
situation is somewhat more complex with the additional hypothesis
of a half-of-the-sites mechanism as shown in Fig. 13B and discussed
below.
3.5. Are there any molecular indications for the non-return of the
electron from bL red?
It can be reasonably assumed that for reasons of coulombic
repulsion, SQ•− remains in the Qof subsite as far as possible from a
reduced bL [13,27]. We already demonstrated that the existence of a
Qo subsite far from bL is not sufﬁcient in itself to impede the return of
electrons from haem bL on a semiquinone species SQ in Qo.
Another hypothesis is the impossibility for an electron to return
without being accompanied by a proton, because the Q2- species
(corresponding to the reduction of the SQ•− species) is improbable
[32]. Indeed, one of the H+ coming from QH2 is supposed to be
transferred with its electron to the ISP head (FeS and His 161) and the
secondH+ is supposed to take a proton pathway close to haem bL [13].
This last H+ which has escaped might not be available to return with
the bL electron to SQ•− (see the discussion of proton release in Ref.
[42] and the double-gated model in Ref. [7]). Furthermore, the proton
return to SQ could be different in the different positions Qof and Qob
possibly occupied by the semiquinone. Thus, the transition of SQ
between the two positions might participate in the gating process and
prevent the type 2 short circuit.
3.6. What brings about a half-of-the-sites reactivity in this model?
We showed that the blockage of the electron return from the
reduced haem bL on a semiquinone molecule at Qo site is necessary to
obtain antimycin inhibition. This inhibition curve is sigmoid since the
electrons are able to take the cross route bL1 b=N bL2. However, we did
not observe the transient activation reported by the group of
Trumpower [23,31]. To explain this transient activation, they
proposed that “whereas free dimers have only one centre P (Qo) site
active at a time, binding of antimycin to one centre N (Qi) activates the
second centre P site, allowing ubiquinol oxidation to proceed in both
monomers simultaneously“. We introduced this half-of-the-sites
reactivity into our model by assuming that the Qo1 and Qi2 sites on
the one hand, and the Qo2 and Qi1 sites on the other, cannot be
occupied simultaneously. This idea comes from the observation that
there are two symmetrical cavities inside the bc1 complex created by
the association of two monomers to form the dimer molecule. One
cavity contains the Qo1 and Qi2 sites; the other, which is symmetrical
and independent, contains the Qo2 and Qi1 sites. Although these
cavities seem quite large, the bulky tail of two UQ10 molecules might
exert steric constraints on them, leading to this alternative binding.
However, this does not hold for antimycin which has no cumbersome
tail. For instance, antimycin bound at Qi2 will not hinder the binding of
QH2 at Qo1 (nor of course at Qo2), so the activity could be increased
just by doubling the Qo binding sites in the presence of one molecule
of antimycin/bc1 dimer. Adding this type of half-of-the-sites reactivity
to the non-return of bL electron on a semiquinone in Qo gives the
curve in Fig. 12 (red curve) showing a transient activation followed by
a quasi-complete inhibition when all the Qi sites are saturated with
Fig. 13. Inhibition pattern dependency for (A) model presented in ﬁgure 9 and (B)
model presented in ﬁgure 12 (half-of-the-sites reactivity), as a function of the binding
of quinone/quinol in Qi. Binding rate constants have been modiﬁed by the following
factors: 1/10000 (red, curve 1); 1/1000 (orange, curve 2); 1/100 (yellow, curve 3); 1/40
(green, curve 4); 1/10 (blue, curve 5); 1/4 (indigo, curve 6); 1 (violet, curve 7); 10
(black, curve 8). Rainbow colors (from red to violet) are from the lowest binding rate
constant to the highest one.
Fig. 12. Proposedmodel of antimycin inhibitionwithhalf-of-the-sites reactivity. Thismodel
assumes that the returnof thesecondelectronof bLredon SQ•- is impossibleas inFig. 9. It also
assumes that Qo1 and Qi2 on the one hand and Qo2 and Qi1 on the other hand cannot be
bound simultaneously due to steric hindrance. This does not apply to antimycin which has
no bulky tail. Red curve, left scale: activity; green curve, right scale: time residence of SQ in
Qo. The black curve (left scale) indicates the net number of bLbound➔ bLfree transitions per
second. Blue: bypass bL➔ Q➔ FeS described in Fig. 11.
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one antimycin molecule bound to the dimer of bc1, e.g. the Qi2 site. In
the absence of antimycin, because there is some quinone occupation
of the Qi sites, the Qo occupation of the other monomer by QH2 is
impeded, as can be seen in Table 1. For instance, 16 to 20% of Qo1H2 or
of Qo2H2 (7th line of Table 1) as compared to 71% (1st line of Table 1)
where no constraint is introduced. Thus, even in the absence of
antimycin, a lower activity in this model (Fig. 12) is observed when
compared to the model without binding constraints (Fig. 9). When
antimycin is present on only one monomer of the bc1 dimer, say on
Qi2, monomer 1 is now fully active, because the antimycin at Qi2 does
not impede the binding of QH2 at Qo1 (nor at Qo2, see the discussion
above). Monomer 2 (with antimycin) can function more or less
normally except that it functions with Qi1 (as in the model of Fig. 9).
The result is an activation for the bc1 dimer which contains only one
antimycin molecule.
Thus we show that the hypothesis of half-of-the-sites reactivity
proposed in Refs. [23,31,39], together with the hypothesis of the non-
return of the electron of reduced bL on a semiquinone at Qo, accounts
quite well for the transient activation of the bc1 complex activity by
antimycin. Obtaining antimycin activation with this model does not
irrefutably demonstrate the half-of-the-sites reactivity mechanism,
but it is nevertheless a strong indication of its possibility.
However, several authors did not ﬁnd any activation feature in the
antimycin inhibition pattern. Fig. 13 shows that this particular
inhibition pattern is highly dependent upon the binding constant of
quinone/quinol in Qi. These simulations demonstrate that the
activation feature in the antimycin inhibition pattern (i) is visible
only with the half-of-the-sites reactivity hypothesis (Fig. 13B), and
that (ii) it depends upon quinone afﬁnity. It can be lost at lower
afﬁnity even with the half-of-the-sites reactivity hypothesis. As noted
above, the latter observation could explain the different shapes of the
experimental curves obtained by Bechman et al. [19] in the presence
of different substrates.
4. Conclusion
A simple model can explain the bifurcation of electrons at Qo due
to a subtle distribution of the probabilities of electron transfer
between the different redox centres. However, there is no underlying
reason why, in this model, antimycin should inhibit bc1 complex
activity. On the contrary, we obtained activation due to the fact that
in the presence of antimycin, the second electron bypasses
transiently through bL to FeS and cytochromes c1 and c, even if the
semiquinone is far from the reduced bL in a distal Qo subsite. To avoid
this bypass, the remoteness of the semiquinone in a Qo subsite distal
from the reduced bL is not a sufﬁcient explanation. It is necessary that
the return of the electron from bL on the semiquinone SQ cannot
occur. We demonstrate here that this hypothesis is sufﬁcient to
obtain antimycin inhibition provided that both Qi sites of the dimer
are occupied. It also shows that the passage of the second electron on
bL, which is prevented in the presence of saturating amounts of
antimycin, is essential to trap the ﬁrst electron on FeS and to allow its
transfer to c1. Otherwise, FeS remains oxidized most of the time
(Table 1) and unable to transfer an electron to c1. This is the main
reason for antimycin inhibition. With only one antimycin site per
dimer, the activity is the same (Fig. 9) or higher if we assume the
existence of half-of-the-sites reactivity (Figs. 12 and 13) due to a
large increase in net non-limiting bL1 b=N bL2 transitions in the
direction of the free Qi site.
The model and the hypothesis on which it is based must now be
tested by their predictions. The ﬁrst consequence of this hypothesis is
the large increase in bL1 b=N bL2 transition for those dimers bound
with only one antimycin molecule. Such peculiar behaviour in the
case of one antimycin per dimer has to be systematically studied in
presteady-state kinetics and in the mutants already available. New
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mutants impeding the transition bL1 b=N bL2. They should transform
the allosteric shape of antimycin inhibition into a hyperbolic one.
Mutants or drugs could be imagined that facilitate the return of the
electron from bL. Such mutants should grow perfectly in the presence
and binding of antimycin without ROS production. The degree of
occupancy of Qo by QH2 could also be measured. In the half-of-the-
sites model it should be dependent on the degree of antimycin
saturation. This would not be the case if the monomers were
independent, so the QH2 occupancy at Qo would be higher (Table 1).
In summary, we underline the interest of our stochastic approach
which does not discard a priori any possible reaction and considers
what actually occurs in a single bc1 molecule. In order to obtain
antimycin inhibition, our model demonstrates the absolute necessity
of a gating mechanism preventing the return of electrons from bL to a
semiquinone in Qo. The parabolic inhibition of antimycin can be
reproduced and depends upon the quinone used (i.e. its afﬁnity for
the Qi site). The introduction of half-of-the-sites reactivity evidences a
stimulation of the bc1 complex activity in the presence of substoichio-
metric concentrations of antimycin.
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